These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8303620)

  • 41. [Leukotriene (B4, C4, D4, E4)].
    Kitamura S
    Nihon Rinsho; 2010 Jul; 68 Suppl 7():38-43. PubMed ID: 20960744
    [No Abstract]   [Full Text] [Related]  

  • 42. Montelukast for persistent asthma.
    Szczeklik A; Mastalerz L; Nizankowska E; Sanak M
    Lancet; 2001 Oct; 358(9291):1456-7. PubMed ID: 11705519
    [No Abstract]   [Full Text] [Related]  

  • 43. Effect of the 5-lipoxygenase inhibitor ZD2138 on aspirin-induced asthma.
    Nasser SM; Bell GS; Foster S; Spruce KE; MacMillan R; Williams AJ; Lee TH; Arm JP
    Thorax; 1994 Aug; 49(8):749-56. PubMed ID: 8091318
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Increased levels of cysteinyl-leukotrienes in saliva, induced sputum, urine and blood from patients with aspirin-intolerant asthma.
    Gaber F; Daham K; Higashi A; Higashi N; Gülich A; Delin I; James A; Skedinger M; Gyllfors P; Nord M; Dahlén SE; Kumlin M; Dahlén B
    Thorax; 2008 Dec; 63(12):1076-82. PubMed ID: 18757457
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Asthma induced by aspirin and arachidonic acid metabolites. II. The role of leukotrienes (part four)].
    Salazar Villa RM; Zambrano Villa S
    Rev Alerg Mex; 1994; 41(6):147-52. PubMed ID: 7834325
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial.
    Dahlén SE; Malmström K; Nizankowska E; Dahlén B; Kuna P; Kowalski M; Lumry WR; Picado C; Stevenson DD; Bousquet J; Pauwels R; Holgate ST; Shahane A; Zhang J; Reiss TF; Szczeklik A
    Am J Respir Crit Care Med; 2002 Jan; 165(1):9-14. PubMed ID: 11779723
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Leukotriene activity modulation in asthma.
    Spector SL
    Drugs; 1997 Sep; 54(3):369-84. PubMed ID: 9279501
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bronchial aspirin challenge causes specific eicosanoid response in aspirin-sensitive asthmatics.
    Szczeklik A; Sladek K; Dworski R; Nizankowska E; Soja J; Sheller J; Oates J
    Am J Respir Crit Care Med; 1996 Dec; 154(6 Pt 1):1608-14. PubMed ID: 8970343
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacogenetics of aspirin-intolerant asthma.
    Kim SH; Hur GY; Choi JH; Park HS
    Pharmacogenomics; 2008 Jan; 9(1):85-91. PubMed ID: 18154450
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Aspirin-induced asthma: pathogenesis and clinical presentation.
    Szczeklik A
    Allergy Proc; 1992; 13(4):163-73. PubMed ID: 1427065
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Asthma with hypersensitivity to aspirin].
    Nizankowska-Mogilnicka E
    Pol Merkur Lekarski; 2003 Jun; 14(84):561-5. PubMed ID: 14524272
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Asthma induced by aspirin and arachidonic acid metabolites. Role of leukotrienes (third part)].
    Salazar Villa RM; Zambrano Villa S
    Rev Alerg Mex; 1994; 41(2):51-7. PubMed ID: 7804810
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increased exhaled cysteinyl-leukotrienes and 8-isoprostane in aspirin-induced asthma.
    Antczak A; Montuschi P; Kharitonov S; Gorski P; Barnes PJ
    Am J Respir Crit Care Med; 2002 Aug; 166(3):301-6. PubMed ID: 12153961
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Effect of hypoxia on nitric oxide formation and leukotriene metabolism in the perfused rat liver].
    Wettstein M; Häussinger D
    Zentralbl Chir; 1994; 119(5):328-33. PubMed ID: 7517604
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tacrolimus reduces urinary excretion of leukotriene E(4) and inhibits aspirin-induced asthma to threshold dose of aspirin.
    Kawano T; Matsuse H; Kondo Y; Machida I; Saeki S; Tomari S; Mitsuta K; Fukushima C; Obase Y; Shimoda T; Kohno S
    J Allergy Clin Immunol; 2004 Dec; 114(6):1278-81. PubMed ID: 15577823
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Leukotrienes, leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthma: an update. Part I: synthesis, receptors and role of leukotrienes in asthma.
    Devillier P; Baccard N; Advenier C
    Pharmacol Res; 1999 Jul; 40(1):3-13. PubMed ID: 10378985
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhaled PGE2 prevents aspirin-induced bronchoconstriction and urinary LTE4 excretion in aspirin-sensitive asthma.
    Sestini P; Armetti L; Gambaro G; Pieroni MG; Refini RM; Sala A; Vaghi A; Folco GC; Bianco S; Robuschi M
    Am J Respir Crit Care Med; 1996 Feb; 153(2):572-5. PubMed ID: 8564100
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Urinary excretion of leukotriene E4 and 11-dehydro-thromboxane B2 in response to bronchial provocations with allergen, aspirin, leukotriene D4, and histamine in asthmatics.
    Kumlin M; Dahlén B; Björck T; Zetterström O; Granström E; Dahlén SE
    Am Rev Respir Dis; 1992 Jul; 146(1):96-103. PubMed ID: 1320824
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mediator release in aspirin-induced reactions.
    Lee TH; Smith CM; Arm JP; Christie PE
    J Allergy Clin Immunol; 1991 Dec; 88(6):827-9. PubMed ID: 1744353
    [No Abstract]   [Full Text] [Related]  

  • 60. Leukotriene modifiers to prevent aspirin-provoked respiratory reactions in asthmatics.
    Volkman JA; Pontikes PJ
    Ann Pharmacother; 2002 Sep; 36(9):1457-61. PubMed ID: 12196067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.